Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (44)
Xiao-Mei Yang, Xiao-Qi Wang, Li-Peng Hu, Ming-Xuan Feng, Yao-Qi Zhou, Dong-Xue Li, Jun Li, Xiao-Cao Miao, Yan-Li Zhang, Lin-Li Yao, Hui-Zhen Nie, Shan Huang, Qiang Xia, Xue-Li Zhang, Shu-Heng Jiang & Zhi-Gang Zhang. (2023) Nucleolar HEAT Repeat Containing 1 Up-regulated by the Mechanistic Target of Rapamycin Complex 1 Signaling Promotes Hepatocellular Carcinoma Growth by Dominating Ribosome Biogenesis and Proteome Homeostasis. Gastroenterology 165:3, pages 629-646.
Crossref
Crossref
Agnete Marie Granau, Pilar Aarøe Andersen, Theresa Jakobsen, Konstantina Taouxi, Nawar Dalila, Johanne Bay Mogensen, Lasse Sommer Kristensen, Kirsten Grønbæk & Konstantinos Dimopoulos. (2023) Concurrent Inhibition of Akt and ERK Using TIC-10 Can Overcome Venetoclax Resistance in Mantle Cell Lymphoma. Cancers 15:2, pages 510.
Crossref
Crossref
K. A. Ivanenko, V. S. Prassolov & E. R. Khabusheva. (2022) Transcription Factor Sp1 in the Expression of Genes Encoding Components of Mapk, JAK/STAT, and PI3K/Akt Signaling Pathways. Molecular Biology 56:5, pages 756-769.
Crossref
Crossref
Hui Li, Jun Liang, Yingying Gao, Min Liu, Nan Xia, Wei Kong, Lisha Zheng, Yikun Zhang, Zutong Li, Hongwei Chen, Shanshan Liu & Lingyun Sun. (2022) IGFBP2 function as a novel biomarker for active lupus nephritis. Journal of Molecular Medicine 100:10, pages 1479-1491.
Crossref
Crossref
Kamal Sweidan, Hussein Elfadel, Dima A. Sabbah, Sanaa K. Bardaweel, Rima Hajjo, Shabana Anjum, Jithna Sinoj, Vidhya A. Nair, Eman Abu‐Gharbieh & Waseem El‐Huneidi. (2022) Novel Derivatives of 4,6‐Dihydroxy‐2‐Quinolone‐3‐Carboxamides as Potential PI3Kα Inhibitors. ChemistrySelect 7:32.
Crossref
Crossref
Flavien Berthou, Cyril Sobolewski, Daniel Abegg, Margot Fournier, Christine Maeder, Dobrochna Dolicka, Marta Correia de Sousa, Alexander Adibekian & Michelangelo Foti. (2022) Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk. International Journal of Molecular Sciences 23:7, pages 3959.
Crossref
Crossref
Yan Liu, Marie V. Nelson, Christopher Bailey, Peng Zhang, Pan Zheng, Jeffrey S. Dome, Yang Liu & Yin Wang. (2021) Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor. Oncogene 40:29, pages 4809-4819.
Crossref
Crossref
Yung-Fa Tsai, Hsiu-Chuan Chou, Ming-Han Liou, En-Chi Liao, Chih-Ting Cheng, Shing-Jyh Chang & Hong-Lin Chan. (2021) Role of IGFBP-2 in oral cancer metastasis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1867:7, pages 166143.
Crossref
Crossref
Muhammad Nazirul Mubin Aziz, Nurul Fattin Che Rahim, Yazmin Hussin, Swee Keong Yeap, Mas Jaffri Masarudin, Nurul Elyani Mohamad, Muhammad Nadeem Akhtar, Mohd Azuraidi Osman, Yoke Kqueen Cheah & Noorjahan Banu Alitheen. (2021) Anti-Metastatic and Anti-Angiogenic Effects of Curcumin Analog DK1 on Human Osteosarcoma Cells In Vitro. Pharmaceuticals 14:6, pages 532.
Crossref
Crossref
Hatim Boughanem, Elena M. Yubero-Serrano, José López-Miranda, Francisco J. Tinahones & Manuel Macias-Gonzalez. (2021) Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance. International Journal of Molecular Sciences 22:3, pages 1133.
Crossref
Crossref
Na Han, Hai-Yan Fang, Jie-Xuan Jiang & Qian Xu. (2020) Downregulation of microRNA-873 attenuates insulin resistance and myocardial injury in rats with gestational diabetes mellitus by upregulating IGFBP2. American Journal of Physiology-Endocrinology and Metabolism 318:5, pages E723-E735.
Crossref
Crossref
Dengke Yang, Haining Qian, Zhen Fang, An Xu, Shutian Zhao, Bingyan Liu & Dong Li. (2019) Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR‐1184/IGFBP2 axis. Cancer Medicine 9:2, pages 700-710.
Crossref
Crossref
Zhen Tang, David Gillatt, Edward Rowe, Anthony Koupparis, Jeff M.P. Holly & Claire M. Perks. (2019) IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells. Oncotarget 10:66, pages 7043-7057.
Crossref
Crossref
Alain P. Gobert, Yvonne L. Latour, Mohammad Asim, Jordan L. Finley, Thomas G. Verriere, Daniel P. Barry, Ginger L. Milne, Paula B. Luis, Claus Schneider, Emilio S. Rivera, Kristie Lindsey-Rose, Kevin L. Schey, Alberto G. Delgado, Johanna C. Sierra, M. Blanca Piazuelo & Keith T. Wilson. (2019) Bacterial Pathogens Hijack the Innate Immune Response by Activation of the Reverse Transsulfuration Pathway. mBio 10:5.
Crossref
Crossref
Dima A. Sabbah, Ameerah H. Ibrahim, Wamidh H. Talib, Khalid M. Alqaisi, Kamal Sweidan, Sanaa K. Bardaweel, Ghassan A. Sheikha, Haizhen A. Zhong, Eveen Al-Shalabi, Reema A. Khalaf & Mohammad S. Mubarak. (2019) Ligand-Based Drug Design: Synthesis and Biological Evaluation of Substituted Benzoin Derivatives as Potential Antitumor Agents. Medicinal Chemistry 15:4, pages 417-429.
Crossref
Crossref
Chi-Neu Tsai, Chia-Lung Tsai, Jui-Shan Yi, Huang-Kai Kao, Yenlin Huang, Chun-I Wang, Yun-Shien Lee & Kai-Ping Chang. (2019) Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells. Scientific Reports 9:1.
Crossref
Crossref
Angel Chao, Chiao-Yun Lin, Ren-Chin Wu, Yun-Shien Lee, Li-Yu Lee, Chia-Lung Tsai, Lan-Yan Yang, Hsuan Liu, Shu-Jen Chen, Tzu-Hao Wang & Chyong-Huey Lai. (2018) The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2. Journal of Molecular Medicine 96:11, pages 1251-1266.
Crossref
Crossref
Shuang Zhao, Lisha Wu, Yehong Kuang, Juan Su, Zhongling Luo, Yan Wang, Jinmao Li, Jianglin Zhang, Wangqing Chen, Fangfang Li, Yijing He, Juan Tao, Jianda Zhou, Xiaowei Xu, Cong Peng & Xiang Chen. (2018) Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression. International Journal of Oncology.
Crossref
Crossref
Malath A. Al-Qtaitat, Mustafa M. El-Abadelah, Dima A. Sabbah, Sanaa Bardaweel, Kamal Sweidan, Salim S. Sabri & Mohammad S. Mubarak. (2018) Synthesis, characterization, and bioactivity of new bisamidrazone derivatives as possible anticancer agents. Medicinal Chemistry Research 27:5, pages 1419-1431.
Crossref
Crossref
Athba Al Qahtani, Jeff Holly & Claire Perks. (2017) Hypoxia negates hyperglycaemia-induced chemo-resistance in breast cancer cells: the role of insulin-like growth factor binding protein 2. Oncotarget 8:43, pages 74635-74648.
Crossref
Crossref
Hoon Hur, Eun Ji Yu, In-Hye Ham, Hye-Jin Jin & Dakeun Lee. (2016) Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients. Oncotarget 8:7, pages 10994-11003.
Crossref
Crossref
Minsang Shin, Hye Suk Kang, Jae-Hyung ParkJae-Hoon BaeDae-Kyu SongSeung-Soon Im. (2017) Recent Insights into Insulin-Like Growth Factor Binding Protein 2 Transcriptional Regulation. Endocrinology and Metabolism 32:1, pages 11.
Crossref
Crossref
Sujit K. Bhutia, Birendra Behera, Durgesh Nandini Das, Subhadip Mukhopadhyay, Niharika Sinha, Prashanta Kumar Panda, Prajna Paramita Naik, Samir K. Patra, Mahitosh Mandal, Siddik Sarkar, Mitchell E. Menezes, Sarmistha Talukdar, Tapas K. Maiti, Swadesh K. Das, Devanand Sarkar & Paul B. Fisher. (2016)
Abrus
agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancer
. International Journal of Cancer 139:2, pages 457-466.
Crossref
Crossref
Xiaofeng Yao, Shanshan Sun, Xuan Zhou, Wenyu Guo & Lun Zhang. (2015) IGF-binding protein 2 is a candidate target of therapeutic potential in cancer. Tumor Biology 37:2, pages 1451-1459.
Crossref
Crossref
Yong-xin Yan, Jun-xia Zhao, Shuo Han, Na-jing Zhou, Zhi-qiang Jia, Sheng-jie Yao, Cui-li Cao, Yan-ling Wang, Yan-nan Xu, Juan Zhao, Yun-li Yan & Hui-xian Cui. (2015) Tetramethylpyrazine induces SH-SY5Y cell differentiation toward the neuronal phenotype through activation of the PI3K/Akt/Sp1/TopoIIβ pathway. European Journal of Cell Biology 94:12, pages 626-641.
Crossref
Crossref
Chiara Giorgi, Aleksandar Boro, Florian Rechfeld, Laura A. Lopez-Garcia, Maria E. Gierisch, Beat W. Schäfer & Felix K. Niggli. (2015) PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1. Oncotarget 6:30, pages 28895-28910.
Crossref
Crossref
Andreas Hoeflich & Vincenzo C. Russo. (2015) Physiology and pathophysiology of IGFBP-1 and IGFBP-2 – Consensus and dissent on metabolic control and malignant potential. Best Practice & Research Clinical Endocrinology & Metabolism 29:5, pages 685-700.
Crossref
Crossref
Li Zeng, Claire M. Perks & Jeff M.P. Holly. (2015) IGFBP-2/PTEN: A critical interaction for tumours and for general physiology?. Growth Hormone & IGF Research 25:3, pages 103-107.
Crossref
Crossref
V.C. Russo, W.J. Azar, S.W. Yau, M.A. Sabin & G.A. Werther. (2015) IGFBP-2: The dark horse in metabolism and cancer. Cytokine & Growth Factor Reviews 26:3, pages 329-346.
Crossref
Crossref
Steven W. Yau, Walid J. Azar, Matthew A. Sabin, George A. Werther & Vincenzo C. Russo. (2015) IGFBP-2 - taking the lead in growth, metabolism and cancer. Journal of Cell Communication and Signaling 9:2, pages 125-142.
Crossref
Crossref
James Beattie, Yousef Hawsawi, Hanaa Alkharobi & Reem El-Gendy. (2015) IGFBP-2 and −5: important regulators of normal and neoplastic mammary gland physiology. Journal of Cell Communication and Signaling 9:2, pages 151-158.
Crossref
Crossref
Hong-Bo Pang, Gary B. Braun, Tomas Friman, Pedro Aza-Blanc, Manuel E. Ruidiaz, Kazuki N. Sugahara, Tambet Teesalu & Erkki Ruoslahti. (2014) An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability. Nature Communications 5:1.
Crossref
Crossref
Minh Truong Do, Hyung Gyun Kim, Thi Thu Phuong Tran, Tilak Khanal, Jae Ho Choi, Young Chul Chung, Tae Cheon Jeong & Hye Gwang Jeong. (2014) Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression. Toxicology and Applied Pharmacology 280:1, pages 138-148.
Crossref
Crossref
Andreas Hoeflich, Elisa Wirthgen, Robert David, Carl Friedrich Classen, Marion Spitschak & Julia Brenmoehl. (2014) Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates. Frontiers in Endocrinology 5.
Crossref
Crossref
Adam P. Sharples, Nasser Al-Shanti, David C. Hughes, Mark P. Lewis & Claire E. Stewart. (2013) The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy. Growth Hormone & IGF Research 23:3, pages 53-61.
Crossref
Crossref
Emily J. Foulstone, Li Zeng, Claire M. Perks & Jeff M. P. Holly. (2013) Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) Promotes Growth and Survival of Breast Epithelial Cells: Novel Regulation of the Estrogen Receptor. Endocrinology 154:5, pages 1780-1793.
Crossref
Crossref
Zicong Li, Zhenfang Wu, Guangcai Ren, Yunxiang Zhao & Dewu Liu. (2012) Expression patterns of insulin-like growth factor system members and their correlations with growth and carcass traits in Landrace and Lantang pigs during postnatal development. Molecular Biology Reports 40:5, pages 3569-3576.
Crossref
Crossref
K B Greer, A Kresak, B Bednarchik, D Dawson, L Li, A Chak & J Willis. (2013) Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis. Clinical and Translational Gastroenterology 4:3, pages e31.
Crossref
Crossref
Tomoka Takao, Kazuo Asanoma, Ryosuke Tsunematsu, Kiyoko Kato & Norio Wake. (2012) The Maternally Expressed Gene Tssc3 Regulates the Expression of MASH2 Transcription Factor in Mouse Trophoblast Stem Cells through the AKT-Sp1 Signaling Pathway. Journal of Biological Chemistry 287:51, pages 42685-42694.
Crossref
Crossref
Aninda Basu, Tao Liu, Pallavi Banerjee, Evelyn Flynn, David Zurakowski, Dipak Datta, Ondrej Viklicky, Martin Gasser, Ana Maria Waaga-Gasser, Jun Yang & Soumitro Pal. (2012) Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression. Cancer Letters 321:2, pages 179-186.
Crossref
Crossref
Zhuo Li, Julie Martin, Paul Poirier, Sarah‐Maude Caron‐Cantin, Frédéric‐Simon Hould, Simon Marceau, Picard Marceau & Frédéric Picard. (2012) Upregulation of Plasma Insulin‐Like Growth Factor Binding Protein 2 Levels After Biliopancreatic Diversion in Humans. Obesity 20:7, pages 1469-1473.
Crossref
Crossref
Zhuo Li, Stéphanie Miard, Mathieu Laplante, Nahum Sonenberg & Frédéric Picard. (2012) Insulin stimulates IGFBP-2 expression in 3T3-L1 adipocytes through the PI3K/mTOR pathway. Molecular and Cellular Endocrinology 358:1, pages 63-68.
Crossref
Crossref
MIN LI, HUAWEN SUN, LUJUN SONG, XIAODONG GAO, WENJU CHANG & XINYU QIN. (2012) Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma. Oncology Letters 4:6, pages 1213-1218.
Crossref
Crossref
Aninda Basu, Pallavi Banerjee, Alan G. Contreras, Evelyn Flynn & Soumitro Pal. (2011) Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40. PLoS ONE 6:8, pages e23919.
Crossref
Crossref